Immune regulation based on the targeting of early activation...

Details Immune regulation based on the targeting of early activation... Immune regulation based on the targeting of early activation...

A - Human Necessities

61

K

A61K 39/395 (2006.01) A61K 31/7088 (2006.01) A61K 39/00 (2006.01) A61K 47/48 (2006.01)

Patent

CA 2513905

Disclosed are methods of treating subjects having disorders or conditions characterized by an unwanted immune response including administering an effective amount of an early activation molecule agonist, antagonist or depletor, to the subject. Human monoclonal antibodies specific to the early activation molecules, and methods of use, are also disclosed.

L'invention concerne des méthodes permettant de traiter des sujets souffrant de troubles ou d'états caractérisés par une réponse immunitaire indésirable, qui consiste à administrer une quantité effficace d'un agoniste de molécule d'activation précoce, un antagoniste ou un agent de déplétion au sujet. L'invention concerne également des anticorps monoclonaux humains spécifiques des molécules d'activation précoce et des méthodes d'utilisation.

Affiliated with

Also associated with

Rating

Immune regulation based on the targeting of early activation... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immune regulation based on the targeting of early activation..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immune regulation based on the targeting of early activation... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1880688